Podcast Episodes

Back to Search
Mailbag Extra: incl. Why not just buy an ETF and avoid the risk? November 28, 2021
Mailbag Extra: incl. Why not just buy an ETF and avoid the risk? November 28, 2021

Season 1 Episode 486

-- A little bit of positive feedback

-- Why aren't my favourite ETFs available in my Super fund?

-- Why are you guys giving stuff away for free?

-- C…

4 years, 4 months ago

Short Long
View Episode
A super-investor's warning for ‘defensive’ investors. November 26, 2021
A super-investor's warning for ‘defensive’ investors. November 26, 2021

Season 1 Episode 485

--The bond market says rates will go up 1.4% by April 2023!

-- The end of the housing boom?

-- $4 billion for Black Friday

-- A super-investor's warn…

4 years, 4 months ago

Short Long
View Episode
Stock of the Week: Nanosonics (ASX:NAN), November 24, 2021
Stock of the Week: Nanosonics (ASX:NAN), November 24, 2021

Season 1 Episode 484

Scott is joined by Motley Fool analyst Andrew Legget to talk about medical technology company Nanosonics (ASX:NAN): What it does, what’s impressive, …

4 years, 4 months ago

Short Long
View Episode
Mailbag Extra: incl. Are insider transactions good signals? November 21, 2021
Mailbag Extra: incl. Are insider transactions good signals? November 21, 2021

Season 1 Episode 483

-- How do execs and directors avoid insider trading?

-- Are insider transactions good signals?

-- What's happening to PolyNovo and Volpara?

-- How do…

4 years, 4 months ago

Short Long
View Episode
ETFs ain't ETFs. November 19, 2021
ETFs ain't ETFs. November 19, 2021

Season 1 Episode 482

-- What? Scott bought Fortescue?

-- Rates, inflation and wages. We're not in Kansas any more, Toto

-- CBA's 20% growth disappoints investors

-- Don't…

4 years, 4 months ago

Short Long
View Episode
Stock of the Week: Australian Clinical Labs (ASX:ACL), November 17, 2021
Stock of the Week: Australian Clinical Labs (ASX:ACL), November 17, 2021

Season 1 Episode 481

Scott is joined by Motley Fool Director of Research Kevin Gandiya to talk about pathology services growth story Australian Clinical Labs (ASX:ACL): W…

4 years, 4 months ago

Short Long
View Episode
Mailbag Extra: incl. What we'd buy if the market tanked. November 14, 2021
Mailbag Extra: incl. What we'd buy if the market tanked. November 14, 2021

Season 1 Episode 480

-- How can I find out what stocks my ETFs hold?

-- Does it matter what I value a company for, if the market disagrees?

-- What would we buy if the ma…

4 years, 4 months ago

Short Long
View Episode
Why efficiency is the enemy of long term success. November 12, 2021
Why efficiency is the enemy of long term success. November 12, 2021

Season 1 Episode 479

-- Pushpay falls off a cliff... value or value trap?

-- How to think about -- and value -- companies at different lifestages

-- Efficiency is the ene…

4 years, 5 months ago

Short Long
View Episode
Stock of the Week: Electro Optic Systems (ASX:EOS), November 10, 2021
Stock of the Week: Electro Optic Systems (ASX:EOS), November 10, 2021

Season 1 Episode 418

Scott is joined by Motley Fool analyst Andrew Legget to talk about space and defence contractor Electro Optic Systems (ASX:EOS): What it does, what’s…

4 years, 5 months ago

Short Long
View Episode
Mailbag Extra: incl. Andrew holds court on cryptocurrency. November 7, 2021
Mailbag Extra: incl. Andrew holds court on cryptocurrency. November 7, 2021

Season 1 Episode 477

-- You want me to pay *how much* for Australian Ethical (ASX:AEF)?

-- Help me find a small cap fund to invest in

-- What's Andrew's investment thesis…

4 years, 5 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us